DrugPatentWatch Database Preview
Details for Patent: 7,781,448
Which drugs does patent 7,781,448 protect, and when does it expire?
This patent has thirteen patent family members in eleven countries.
Summary for Patent: 7,781,448
Title: | Once daily dosage forms of trospium |
Abstract: | A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (C.sub.min) and maximum (C.sub.max) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively. |
Inventor(s): | Kidane; Argaw (Montgomery Village, MD), Flanner; Henry H. (Montgomery Village, MD), Bhatt; Padmanabh (Rockville, MD), Raoufinia; Arash (McLean, VA) |
Assignee: | Supernus Pharmaceuticals, Inc. (Rockville, MD) |
Application Number: | 11/889,962 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; Formulation; Use; |
Drugs Protected by US Patent 7,781,448
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allergan | SANCTURA XR | trospium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 022103-001 | Aug 3, 2007 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | METHOD OF TREATING BLADDER DSYFUNCTION WITH ONCE A DAY TROSPIUM SALT FORMULATION | ➤ Sign Up | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Non-Orange Book US Patents Family Members for Patent 7,781,448
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
7,763,635 | Once daily dosage forms of trospium | ➤ Sign Up |
7,781,449 | Trospium chloride treatment method | ➤ Sign Up |
7,410,978 | Once daily dosage forms of trospium | ➤ Sign Up |
7,759,359 | Method of treating bladder dysfunction with once-a-day trospium salt formulation | ➤ Sign Up |
Patent No. | Title | Estimated Patent Expiration |
International Family Members for US Patent 7,781,448
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 493981 | ➤ Sign Up | |||
Australia | 2004289223 | ➤ Sign Up | |||
Canada | 2537103 | ➤ Sign Up | |||
Germany | 602004030931 | ➤ Sign Up | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |